The frontiers

Vestibular implants

If a cochlear implant can replace a deaf ear’s hearing, can a device replace a dead labyrinth’s sense of motion? For bilateral vestibular loss — where nothing else restores function — that is the promise.

The unmet need

Bilateral vestibulopathy is the hardest vestibular problem to treat: with both labyrinths failing, there is no healthy side to drive central compensation, and patients are left with oscillopsia and imbalance that rehabilitation can only partly offset. The vestibular implant targets exactly this gap — restoring, rather than compensating for, lost input.

How it works

The device mirrors the cochlear implant: motion sensors (gyroscopes) detect head rotation, a processor encodes it, and electrodes implanted near the ampullary nerves of the semicircular canals deliver modulated electrical stimulation that the brain reads as head movement. Early work showed the human vestibular system can adapt to baseline electrical stimulation,1 and later prototypes restored measurable dynamic visual acuity and vestibulo-ocular responses during head motion.2,3

Where it stands

Vestibular implantation is in early clinical testing, not routine care. First-in-human studies demonstrate partial restoration of gaze stabilisation and postural control, but challenges remain: refining motion-encoding algorithms, optimising electrode placement to stimulate the intended canal without current spread, preserving any residual hearing, and defining who benefits most. It is the clearest example of the chapter’s theme — replacement rather than suppression — and the one most likely to reach selected patients first.

Key points

  • The vestibular implant targets bilateral vestibulopathy, where compensation is impossible.
  • It senses head motion and stimulates the ampullary nerves — a cochlear-implant analogue.
  • Early human trials restore dynamic visual acuity and vestibulo-ocular responses.
  • It is early clinical, not routine; encoding, electrode targeting and selection are unsolved.